Of Bio-chemic system
Biochemic system medicaments, measured-dose therapeutic preparations
HSN 3004 90 15 (Of Bio-chemic system) is subject to regulatory controls administered by the Ministry of Environment, Forest and Climate Change (MEFCC) and import-policy conditions issued by the Directorate General of Foreign Trade (DGFT) under ITC (HS) policy. Import of oxytocin under this tariff line is prohibited; import of oxytocin reference standards is permitted exclusively for test and analysis subject to a test licence from DGCI/CDSCO under S.O. 2357(E) and DGFT Notification 09/2015-2020 dated 23-05-2022.
- Certificate of Analysis from DGCI/CDSCO
- Batch release certificate from manufacturer
- Label of consignment from importer
Procedural directions for customs clearance are issued by: Directorate General of Foreign Trade.
- 1Verify that the product to be imported is not oxytocin in formulated/finished form — such import is prohibited under S.O. 2357(E) and DGFT Notification 09/2015-2020 dated 23-05-2022. If importing oxytocin reference standards for test and analysis only, obtain a valid test licence from DGCI/CDSCO before filing the bill of entry.S.O. 2357(E) dated 23-05-2022 · DGFT Notification 09/2015-2020 dated 23-05-2022
- 2Upload the mandatory e-Sanchit documents before out-of-charge: Certificate of Analysis — Drug (document code 0010dc), Batch Release Certificate (document code 0030dc), and Label of Consignment (document code 0110dc). Bills not routed through the PGA for NOC are subject to verification by the proper officer at the bill-of-entry stage.CBIC e-Sanchit document codes 0010dc, 0030dc, 0110dc · CCR customs-officer instruction
- 3Where importing used or refurbished medical equipment of high-end or high-value categories under this heading, comply with the conditions prescribed by MEFCC in the O.M. dated 15-12-2023; such imports are Restricted and subject to DGHS-specified conditions that are additional to the standard PGA document set.O.M. issued by Ministry of Environment, Forest and Climate Change dated 15-12-2023
The most common error on this tariff line is conflating the oxytocin prohibition with the broader biochemic-system product category. The prohibition applies specifically to oxytocin in its finished/formulated form; oxytocin reference standards for test and analysis remain permissible but require a DGCI/CDSCO test licence uploaded in e-Sanchit — absent that licence, the consignment will be detained and risks confiscation as a prohibited import, regardless of the general biochemic-medicament classification of the tariff line.